• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hypertension and overweight].

作者信息

Slany Jörg

机构信息

Präsident der Osterreichischen Gesellschaft für Hypertensiologie, Wien, Austria.

出版信息

Wien Med Wochenschr. 2008;158(13-14):370-2. doi: 10.1007/s10354-008-0560-9.

DOI:10.1007/s10354-008-0560-9
PMID:18677587
Abstract

Obesity shows a strong association with hypertension, primarily due to secretion of an abundance of para- and endocrine peptides by the visceral adipose tissue that play a key role in the pathogenesis of high blood pressure and are responsible for the accelerated atherothrombosis encountered in overweight individuals. Increased activity of the RAAS and the sympathetic nerve system are the main pathophysiologic factors; hypertension in obese subjects is characterized by increased peripheral arterial resistance, high cardiac output, hypervolemia and salt sensitivity. Medical therapy sees blockade of the RAAS in front. Priority in treatment should be given to improvements in life style, primarily in increasing physical activity and decreasing caloric intake, and to medical treatment of associated risk factors according to the modern concept of global risk management.

摘要

相似文献

1
[Hypertension and overweight].
Wien Med Wochenschr. 2008;158(13-14):370-2. doi: 10.1007/s10354-008-0560-9.
2
Secondary hypertension: obesity and the metabolic syndrome.继发性高血压:肥胖与代谢综合征
J Clin Hypertens (Greenwich). 2008 Jul;10(7):567-74. doi: 10.1111/j.1751-7176.2008.08178.x.
3
[Hypertension in obese patients: Pathophysiology and management].[肥胖患者的高血压:病理生理学与管理]
Presse Med. 2009 Apr;38(4):609-13. doi: 10.1016/j.lpm.2009.01.006. Epub 2009 Feb 23.
4
The treatment of hypertension in obese patients.肥胖患者的高血压治疗。
Curr Hypertens Rep. 2008 Apr;10(2):143-50. doi: 10.1007/s11906-008-0027-9.
5
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.肥胖与高血压:机制、心肾后果及治疗方法
Med Clin North Am. 2009 May;93(3):733-51. doi: 10.1016/j.mcna.2009.02.010.
6
[Obesity-related hypertension].[肥胖相关性高血压]
Ned Tijdschr Geneeskd. 2011;154:A1945.
7
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.进展与争议:在高血压背景下治疗肥胖和胰岛素抵抗
J Clin Hypertens (Greenwich). 2009 Jan;11(1):36-41. doi: 10.1111/j.1751-7176.2008.00065.x.
8
Pathophysiology and treatment of the obesity-related arterial hypertension.肥胖相关动脉高血压的病理生理学与治疗
Acta Clin Belg Suppl. 1992;14:18-25. doi: 10.1080/17843286.1992.11718272.
9
Mechanisms linking obesity to hypertension.肥胖与高血压的关联机制。
Obes Rev. 2012 Jan;13(1):17-26. doi: 10.1111/j.1467-789X.2011.00914.x. Epub 2011 Aug 10.
10
[Treatment of hypertension in obesity].[肥胖症中的高血压治疗]
Herz. 2001 May;26(3):209-21. doi: 10.1007/pl00002023.

本文引用的文献

1
The association of waist circumference with ambulatory blood pressure is independent of alternative adiposity indices.腰围与动态血压之间的关联独立于其他肥胖指标。
J Hypertens. 2007 Sep;25(9):1798-806. doi: 10.1097/HJH.0b013e3281e6666f.
2
Long-term mortality after gastric bypass surgery.胃旁路手术后的长期死亡率。
N Engl J Med. 2007 Aug 23;357(8):753-61. doi: 10.1056/NEJMoa066603.
3
Body weight changes with beta-blocker use: results from GEMINI.使用β受体阻滞剂后的体重变化:来自GEMINI研究的结果
Am J Med. 2007 Jul;120(7):610-5. doi: 10.1016/j.amjmed.2006.10.017.
4
Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome.代谢综合征患者对膳食盐的血压反应性增加。
J Hum Hypertens. 2007 Jun;21(6):438-44. doi: 10.1038/sj.jhh.1002153. Epub 2007 Feb 1.
5
Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study.高血压前期和高血压患者自童年起代谢综合征变量的变化:博加卢萨心脏研究
Hypertension. 2006 Jul;48(1):33-9. doi: 10.1161/01.HYP.0000226410.11198.f4. Epub 2006 Jun 12.
6
Diagnosis and management of hypertension in obesity.肥胖症患者高血压的诊断与管理
Obes Rev. 2006 May;7(2):155-62. doi: 10.1111/j.1467-789X.2006.00226.x.
7
Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.
Int J Obes (Lond). 2005 May;29(5):509-16. doi: 10.1038/sj.ijo.0802887.
8
Weight loss and the renin-angiotensin-aldosterone system.体重减轻与肾素-血管紧张素-醛固酮系统
Hypertension. 2005 Mar;45(3):356-62. doi: 10.1161/01.HYP.0000154361.47683.d3. Epub 2005 Jan 3.
9
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.难治性高血压患者中未被识别的睡眠呼吸暂停患病率高。
J Hypertens. 2001 Dec;19(12):2271-7. doi: 10.1097/00004872-200112000-00022.
10
Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997.1982年至1997年芬兰高血压和血压正常人群的血压水平及肥胖趋势。
J Hypertens. 2000 Mar;18(3):255-62. doi: 10.1097/00004872-200018030-00003.